1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Exports
  5. Export of Heparin for Th…

Export of heparin for therapeutic use from Hong Kong: Decline in 2017

United Nations Statistical Office reported that the variable went down strongly by 82.27 percent in 2017. The indicator greatly decreased from 5 137 966 US Dollar to 911 020.81 US Dollar, contrarily to the prior year when it increased by 0.03 percent. Hong Kong saw a decline of 67.86% in pharmaceutical export during the last 25 years. As well as it has attained the compound average annual growth rate of 0.16 percent over the last five years with a negligible overall raise since the start of observations. It averaged 1 134 307.59 US Dollar from 1993 to 2017 and it attained its all-time high of 5 137 966 US Dollar in 2016 and record low of 12 948 US Dollar in 2005.

Export of heparin for therapeutic use from Hong Kong: Decline in 2017
Date US Dollar Variation
2017 911 020.81 -82.27
2016 5 137 966.00 0.03
2015 5 136 681.00 1137.08
2014 415 226.00 -4.22
2013 433 534.00 52.67
2012 283 959.00 -5.93
2011 301 851.00 200.66
2010 100 397.00 -76.6
2009 429 011.00 572.28
2008 63 814.00 46.89

Related Statistics

Pharmaceutical Exports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales